2012
DOI: 10.1016/j.amjcard.2012.07.025
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Clopidogrel Loading Dose in Patients With Chronic Kidney Disease Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…One study was excluded due to lack of subgroup analysis for STEMI patients, 7 and 3 were excluded as they used the same data as other included studies. [8][9][10] Nine studies, published between 2009 and 2012, were included in the final analysis [11][12][13][14][15][16][17][18][19] ( Figure 1 and Table 1). These studies included a total of 18 623 patients, 9231 in the 600-mg group and 9392 in the 300-mg group.…”
Section: Resultsmentioning
confidence: 99%
“…One study was excluded due to lack of subgroup analysis for STEMI patients, 7 and 3 were excluded as they used the same data as other included studies. [8][9][10] Nine studies, published between 2009 and 2012, were included in the final analysis [11][12][13][14][15][16][17][18][19] ( Figure 1 and Table 1). These studies included a total of 18 623 patients, 9231 in the 600-mg group and 9392 in the 300-mg group.…”
Section: Resultsmentioning
confidence: 99%
“…Data in the KAMIR revealed that the standard loading dose clopidogrel group had similar clinical results compared with the double loading dose group before PCI [38,39]. Low-molecular-weight heparin was associated with a better clinical outcome than unfractionated heparin in patients with AMI [40,41,42].…”
Section: Treatment Of Amimentioning
confidence: 99%